QUARTERLY RESULTS Shilpa Medicare Q4 Results: Net profit jumps over 7x to Rs 108 crore, revenue up 32% 3:08 PM IST
CORPORATES Shilpa Medicare signs strategic licensing agreement with SteinCares to commercialize biosimilar in Latin America Feb 24, 2026
QUARTERLY RESULTS Shilpa Medicare Q3 Results: Revenue jumps 28.3% YoY to Rs 409.73 crore, net profit up 40.3% Feb 6, 2026
Stock to Watch: Shilpa Medicare reports robust Q2 FY25 performance with 11% revenue growth and 1008% PAT increase Nov 14, 2024
Shilpa Medicare announces USFDA acceptance of NDA for Oxylanthanum Carbonate filed by Unicycive Nov 12, 2024
Shilpa Medicare shares jump 3% as CDMO customer secures USFDA Fast Track Designation for GBM Drug Oct 16, 2024
Shilpa Medicare shares rise 4% to after Antique initiates ‘Buy’ rating with target price of ₹1300 Sep 16, 2024
Shilpa Medicare Stock: Share price surges 9% this week on USFDA approval for Bortezomib Injection Aug 31, 2024